I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.
The market is in a transitional phase as we await earnings.
I’m heavily weighted in this one sector, while adding to one name on news.
I’m reducing some positions, but adding this highly speculative, low-priced data center name.